Seres Therapeutics Statistics

Total Valuation

MCRB has a market cap or net worth of $128.14 million. The enterprise value is $165.31 million.

Market Cap	128.14M
Enterprise Value	165.31M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

MCRB has 170.20 million shares outstanding. The number of shares has increased by 14.47% in one year.

Current Share Class	170.20M
Shares Outstanding	170.20M
Shares Change (YoY)	+14.47%
Shares Change (QoQ)	+0.75%
Owned by Insiders (%)	0.58%
Owned by Institutions (%)	23.80%
Float	124.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.93
Forward PS	n/a
PB Ratio	5.79
P/TBV Ratio	5.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 3.91.

Current Ratio	1.12
Quick Ratio	1.03
Debt / Equity	3.91
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.96

Financial Efficiency

Return on equity (ROE) is -1,556.28% and return on invested capital (ROIC) is -16.84%.

Return on Equity (ROE)	-1,556.28%
Return on Assets (ROA)	-9.70%
Return on Capital (ROIC)	-16.84%
Revenue Per Employee	$542,167
Profits Per Employee	-$109,335
Employee Count	233
Asset Turnover	0.46
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.68% in the last 52 weeks. The beta is 2.05, so MCRB's price volatility has been higher than the market average.

Beta (5Y)	2.05
52-Week Price Change	-42.68%
50-Day Moving Average	0.83
200-Day Moving Average	0.90
Relative Strength Index (RSI)	57.18
Average Volume (20 Days)	3,209,162

Short Selling Information

The latest short interest is 17.85 million, so 10.49% of the outstanding shares have been sold short.

Short Interest	17.85M
Short Previous Month	18.05M
Short % of Shares Out	10.49%
Short % of Float	14.36%
Short Ratio (days to cover)	5.75

Income Statement

In the last 12 months, MCRB had revenue of $126.33 million and -$25.48 million in losses. Loss per share was -$0.18.

Revenue	126.33M
Gross Profit	23.26M
Operating Income	-42.39M
Pretax Income	-82.68M
Net Income	-25.48M
EBITDA	-36.50M
EBIT	-42.39M
Loss Per Share	-$0.18

Full Income Statement

Balance Sheet

The company has $66.82 million in cash and $93.61 million in debt, giving a net cash position of -$26.79 million or -$0.16 per share.

Cash & Cash Equivalents	66.82M
Total Debt	93.61M
Net Cash	-26.79M
Net Cash Per Share	-$0.16
Equity (Book Value)	23.92M
Book Value Per Share	0.14
Working Capital	8.10M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 18.41%, with operating and profit margins of -33.56% and -20.17%.

Gross Margin	18.41%
Operating Margin	-33.56%
Pretax Margin	-54.18%
Profit Margin	-20.17%
EBITDA Margin	-28.89%
EBIT Margin	-33.56%
FCF Margin	-63.05%

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.47%
Shareholder Yield	-14.47%
Earnings Yield	-18.39%
FCF Yield	n/a

Analyst Forecast

The average price target for MCRB is $5.63, which is 647.78% higher than the current price. The consensus rating is "Buy".

Price Target	$5.63
Price Target Difference	647.78%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	21.92%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MCRB has an Altman Z-Score of -6.98 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.98
Piotroski F-Score	2